Literature DB >> 20412062

Pigment epithelium-derived factor binds to cell-surface F(1)-ATP synthase.

Luigi Notari1, Naokatu Arakaki, David Mueller, Scott Meier, Juan Amaral, S P Becerra.   

Abstract

Pigment epithelium-derived factor (PEDF), a potent blocker of angiogenesis in vivo, and of endothelial cell migration and tubule formation, binds with high affinity to an as yet unknown protein on the surfaces of endothelial cells. Given that protein fingerprinting suggested a match of a approximately 60 kDa PEDF-binding protein in bovine retina with Bos taurus F(1)-ATP synthase beta-subunit, and that F(1)F(o)-ATP synthase components have been identified recently as cell-surface receptors, we examined the direct binding of PEDF to F(1). Size-exclusion ultrafiltration assays showed that recombinant human PEDF formed a complex with recombinant yeast F(1). Real-time binding as determined by surface plasmon resonance demonstrated that yeast F(1) interacted specifically and reversibly with human PEDF. Kinetic evaluations revealed high binding affinity for PEDF, in agreement with PEDF affinities for endothelial cell surfaces. PEDF blocked interactions between F(1) and angiostatin, another antiangiogenic factor, suggesting overlapping PEDF-binding and angiostatin-binding sites on F(1). Surfaces of endothelial cells exhibited affinity for PEDF-binding proteins of approximately 60 kDa. Antibodies to F(1)beta-subunit specifically captured PEDF-binding components in endothelial plasma membranes. The extracellular ATP synthesis activity of endothelial cells was examined in the presence of PEDF. PEDF significantly reduced the amount of extracellular ATP produced by endothelial cells, in agreement with direct interactions between cell-surface ATP synthase and PEDF. In addition to demonstrating that PEDF binds to cell-surface F(1), these results show that PEDF is a ligand for endothelial cell-surface F(1)F(o)-ATP synthase. They suggest that PEDF-mediated inhibition of ATP synthase may form part of the biochemical mechanisms by which PEDF exerts its antiangiogenic activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20412062      PMCID: PMC2929661          DOI: 10.1111/j.1742-4658.2010.07641.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  41 in total

1.  AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization.

Authors:  Keisuke Mori; Peter Gehlbach; Satoru Yamamoto; Elia Duh; Donald J Zack; Quihong Li; Kenneth I Berns; Brian J Raisler; William W Hauswirth; Peter A Campochiaro
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-06       Impact factor: 4.799

2.  Binding of pigment epithelium-derived factor (PEDF) to retinoblastoma cells and cerebellar granule neurons. Evidence for a PEDF receptor.

Authors:  E Alberdi; M S Aymerich; S P Becerra
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

3.  Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease.

Authors:  J Spranger; M Osterhoff; M Reimann; M Möhlig; M Ristow; M K Francis; V Cristofalo; H P Hammes; G Smith; M Boulton; A F Pfeiffer
Journal:  Diabetes       Date:  2001-12       Impact factor: 9.461

4.  Evidence for pigment epithelium-derived factor receptors in the neural retina.

Authors:  M S Aymerich; E M Alberdi; A Martínez; S P Becerra
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-12       Impact factor: 4.799

5.  Expression of pigment epithelium-derived factor in experimental choroidal neovascularization.

Authors:  Reem Z Renno; Ayman I Youssri; Norman Michaud; Evangelos S Gragoudas; Joan W Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-05       Impact factor: 4.799

6.  Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor.

Authors:  V Stellmach; S E Crawford; W Zhou; N Bouck
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-23       Impact factor: 11.205

7.  Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization.

Authors:  K Mori; E Duh; P Gehlbach; A Ando; K Takahashi; J Pearlman; K Mori; H S Yang; D J Zack; D Ettyreddy; D E Brough; L L Wei; P A Campochiaro
Journal:  J Cell Physiol       Date:  2001-08       Impact factor: 6.384

8.  Pigment epithelium-derived factor delays the death of photoreceptors in mouse models of inherited retinal degenerations.

Authors:  M Cayouette; S B Smith; S P Becerra; C Gravel
Journal:  Neurobiol Dis       Date:  1999-12       Impact factor: 5.996

9.  Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity.

Authors:  S E Crawford; V Stellmach; M Ranalli; X Huang; L Huang; O Volpert; G H De Vries; L P Abramson; N Bouck
Journal:  J Cell Sci       Date:  2001-12       Impact factor: 5.285

10.  Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin.

Authors:  T L Moser; D J Kenan; T A Ashley; J A Roy; M D Goodman; U K Misra; D J Cheek; S V Pizzo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

View more
  26 in total

Review 1.  New insights regarding the regulation of chemotaxis by nucleotides, adenosine, and their receptors.

Authors:  Ross Corriden; Paul A Insel
Journal:  Purinergic Signal       Date:  2012-04-15       Impact factor: 3.765

2.  Inhibition of tumor cell surface ATP synthesis by pigment epithelium-derived factor: implications for antitumor activity.

Authors:  Monika Deshpande; Luigi Notari; Preeti Subramanian; Vicente Notario; S Patricia Becerra
Journal:  Int J Oncol       Date:  2012-04-10       Impact factor: 5.650

Review 3.  Pigment epithelium-derived factor as an anticancer drug and new treatment methods following the discovery of its receptors: a patent perspective.

Authors:  Katrina B Manalo; Peter F M Choong; S Patricia Becerra; Crispin R Dass
Journal:  Expert Opin Ther Pat       Date:  2011-01-05       Impact factor: 6.674

4.  Opposing effects of pigment epithelium-derived factor on breast cancer cell versus neuronal survival: implication for brain metastasis and metastasis-induced brain damage.

Authors:  Daniel P Fitzgerald; Preeti Subramanian; Monika Deshpande; Christian Graves; Ira Gordon; Yongzhen Qian; Yeva Snitkovsky; David J Liewehr; Seth M Steinberg; José D Paltán-Ortiz; Mary M Herman; Kevin Camphausen; Diane Palmieri; S Patricia Becerra; Patricia S Steeg
Journal:  Cancer Res       Date:  2012-01-01       Impact factor: 12.701

5.  Recombinant pigment epithelium-derived factor PEDF binds vascular endothelial growth factor receptors 1 and 2.

Authors:  Erin K Johnston; Mary K Francis; Janice E Knepper
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-05-07       Impact factor: 2.416

Review 6.  Natural products and other inhibitors of F1FO ATP synthase.

Authors:  Bhargav A Patel; Terin L D'Amico; Brian S J Blagg
Journal:  Eur J Med Chem       Date:  2020-09-03       Impact factor: 6.514

7.  Pigment epithelium-derived factor (PEDF) shares binding sites in collagen with heparin/heparan sulfate proteoglycans.

Authors:  Atsushi Sekiya; Hitomi Okano-Kosugi; Chisato M Yamazaki; Takaki Koide
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

8.  ATP release mechanisms of endothelial cell-mediated stimulus-dependent hyperalgesia.

Authors:  Elizabeth K Joseph; Paul G Green; Jon D Levine
Journal:  J Pain       Date:  2014-05-02       Impact factor: 5.820

Review 9.  The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential.

Authors:  S Patricia Becerra; Vicente Notario
Journal:  Nat Rev Cancer       Date:  2013-03-14       Impact factor: 60.716

10.  Emetine Di-HCl Attenuates Type 1 Diabetes Mellitus in Mice.

Authors:  LaQueta K Hudson; Meghan E Dancho; Jianhua Li; Johanna B Bruchfeld; Ahmed A Ragab; Mingzhu M He; Meaghan Bragg; Delaney Lenaghan; Michael D Quinn; Jason R Fritz; Matthew V Tanzi; Harold A Silverman; William M Hanes; Yaakov A Levine; Valentin A Pavlov; Peder S Olofsson; Jesse Roth; Yousef Al-Abed; Ulf Andersson; Kevin J Tracey; Sangeeta S Chavan
Journal:  Mol Med       Date:  2016-06-10       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.